At present, there are no proven agents for treatment of coronavirus disease (COVID-19). The
available evidence has not allowed guidelines to clearly recommend any drugs outside the …

Background As the novel SARS-CoV-2 pandemic occurred, no specific treatment was yet
available. Inflammatory response secondary to viral infection might be the driver of severe …

Background: Coronavirus disease 2019 (COVID-19) has infected more than 4.4 million
people and caused more than 300,000 deaths partly through acute respiratory distress …

Little is known about the clinical features and outcomes of SARS-CoV-2 infection in Africa.
We conducted a retrospective cohort study of patients hospitalized for COVID-19 between …

Introducción: La pandemia por SARS-Cov-2 ha tenido un impacto negativo en múltiples
aspectos de la vida humana, tanto en lo físico, psicológico, económico, social y cultural. Las …

Herein, we have summarized and argued about biomarkers and indicators used for the
detection of severe acute respiratory syndrome coronavirus 2. Antibody detection methods …

Cytokine storm syndrome (CSS) is a severe complication of inflammatory immune diseases
or treatment of malignancies; it may also appear during the progression of COVID-19. CSS …

COVID-19 caused by the SARS-CoV-2 virus, accompanies an unprecedented spike in
cytokines levels termed cytokines release syndrome (CRS), in critically ill patients. Clinicians …

Coronavirus disease 2019 (COVID-19) is an emerging human infectious disease caused by
a novel b coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

In this paper, a model is proposed of the pathophysiological processes of COVID-19 starting
from the infection of human type II alveolar epithelial cells (pneumocytes) by SARS-CoV-2 …